Yankees Score with ...
Health Care: Health Services
Thoratec Corporation (THOR: NASDAQ)
$31.39 -0.13 | -0.41%
05/24/13 - 04:00 PM ET
490.14K / 665.20K
Vol / Avg. Vol:31.41 / 31.52
Open / Prev. Close:31.15 - 31.56
Today's Range:29.39 - 39.86
52 Wk Range:-15.99%
Performance YTD:TheStreet Rating:
Portfolios with THOR
- Portfolio NameUser Type
- Usermy portfolio
- ContributorStocks Rising On Unusual Vo...
- ContributorMost-Searched Stocks for th...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Health Care Stocks With ...
- UserAberian System, MEDICAL stocks
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Best-Rate...
- UserJust Lookin'
- UserPART 5 JPMorgan 28th Annual...
Latest THOR Headlines from TheStreet
- Thoratec Is Now Oversold (THOR) 05.20.13 | 12:05 pm
- 4 Stocks Dragging The Health Services Industry Downward 05.03.13 | 01:05 pm
- THOR Makes Notable Cross Below Critical Moving Average 04.18.13 | 11:04 am
- 8 Stocks Climbing Higher on Unusual Volume 11.21.12 | 02:11 pm
- Sunshine Heart: A Promising Treatment for Heart Failure Patients 11.05.12 | 08:11 am
- Analysts' Actions: TXN HAL DFS CELG THOR 10.03.12 | 10:10 am
- Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 11:08 pm
- Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 11:05 pm
- 7 Hot Stocks on Traders' Radars 04.05.12 | 11:04 am
- Analysts' Actions: CSCO, MMM, CIT, AMGN, S 02.09.12 | 09:02 am
Press Releases for THOR
- Meet Ms. Joe Ann Bivins, The World's Longest-Supported Recipient Of A Single Heart Assist Device - PR Newswire 03.19.13 | 09:03 am
- Thoratec Announces The First Human Use Of HeartMate PHPâ¿¢ - PR Newswire 03.18.13 | 08:03 am
- Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast - PR Newswire 03.11.13 | 04:03 pm
- Thoratec Presentation At Leerink Swann Global Healthcare Conference To Be Webcast - PR Newswire 02.11.13 | 08:02 am
- Thoratec Schedules Fourth Quarter Conference Call, Webcast - PR Newswire 01.28.13 | 09:01 am
- Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II® - PR Newswire 01.07.13 | 08:01 am
- Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast - PR Newswire 01.03.13 | 08:01 am
- Thoratec Announces Approval For HeartMate II® In Japan - PR Newswire 12.11.12 | 08:12 am
- Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast - PR Newswire 12.10.12 | 02:12 pm
- Thoratec Announces $150 Million Share Repurchase Authorization - PR Newswire 11.26.12 | 08:11 am
Partner Headlines for THOR
- Bull of the Day: Thoratec Corp. (THOR) - Bull of the Day - Zacks 12.07.12 | 01:12 am
- Stocks Hold Modest Gains; Stratasys Breaks Out - Investor's Business Daily 11.21.12 | 01:11 pm
- Thoratec Achieves 52-Week High - Analyst Blog - Zacks 11.05.12 | 06:11 pm
- Heart Failure: 'New Epidemic' Creates New Opportunities For Investors - Seeking Alpha 11.04.12 | 08:11 am
- Abiomed Beats 2Q Ests, Profit Jumps - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Thoratec Corporation (THOR) - Bull of the Day - Zacks 10.10.12 | 01:10 am
- FDA Approves Abiomed's Impella CP - Analyst Blog - NASDAQ 09.11.12 | 11:09 pm
- FDA Approves Abiomed's Impella CP - Analyst Blog - Zacks 09.11.12 | 07:09 pm
- 3 Healthcare Stocks With Positive Momentum - Seeking Alpha 09.01.12 | 08:09 am
- Abiomed Reaffirmed at Neutral - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
